BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23614051)

  • 1. The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study.
    Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
    PLoS One; 2013; 8(4):e62487. PubMed ID: 23614051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine tumor epidemiology: contrasting Norway and North America.
    Hauso O; Gustafsson BI; Kidd M; Waldum HL; Drozdov I; Chan AK; Modlin IM
    Cancer; 2008 Nov; 113(10):2655-64. PubMed ID: 18853416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan.
    Chang JS; Chen LT; Shan YS; Chu PY; Tsai CR; Tsai HJ
    Sci Rep; 2021 Apr; 11(1):7881. PubMed ID: 33846396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.
    Navalkele P; O'Dorisio MS; O'Dorisio TM; Zamba GK; Lynch CF
    Pediatr Blood Cancer; 2011 Jan; 56(1):50-7. PubMed ID: 21108439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence and survival of pancreatic cancer by histology, including rare subtypes: a nation-wide cancer registry-based study from Taiwan.
    Chang JS; Chen LT; Shan YS; Chu PY; Tsai CR; Tsai HJ
    Cancer Med; 2018 Nov; 7(11):5775-5788. PubMed ID: 30264519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancers in patients with neuroendocrine tumors.
    Tsai HJ; Wu CC; Tsai CR; Lin SF; Chen LT; Chang JS
    PLoS One; 2013; 8(12):e86414. PubMed ID: 24392036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
    Dasari A; Shen C; Halperin D; Zhao B; Zhou S; Xu Y; Shih T; Yao JC
    JAMA Oncol; 2017 Oct; 3(10):1335-1342. PubMed ID: 28448665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic trends in neuroendocrine tumors: An examination of incidence rates and survival of specific patient subgroups over the past 20 years.
    Sackstein PE; O'Neil DS; Neugut AI; Chabot J; Fojo T
    Semin Oncol; 2018 Aug; 45(4):249-258. PubMed ID: 30348533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971.
    Ellis L; Shale MJ; Coleman MP
    Am J Gastroenterol; 2010 Dec; 105(12):2563-9. PubMed ID: 20823835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States.
    Lee MR; Harris C; Baeg KJ; Aronson A; Wisnivesky JP; Kim MK
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2212-2217.e1. PubMed ID: 30580091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine tumors: a population-based study of incidence and survival in Girona Province, 1994-2004.
    Alsina M; Marcos-Gragera R; Capdevila J; Buxó M; Ortiz RM; Barretina P; Vilardell L; Brunet J; Beltran M; Izquierdo Á
    Cancer Epidemiol; 2011 Dec; 35(6):e49-54. PubMed ID: 21840785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
    Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
    Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.
    Yao JC; Hassan M; Phan A; Dagohoy C; Leary C; Mares JE; Abdalla EK; Fleming JB; Vauthey JN; Rashid A; Evans DB
    J Clin Oncol; 2008 Jun; 26(18):3063-72. PubMed ID: 18565894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia.
    Wyld D; Wan MH; Moore J; Dunn N; Youl P
    Cancer Epidemiol; 2019 Dec; 63():101598. PubMed ID: 31539715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    Masui T; Ito T; Komoto I; Uemoto S;
    BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution, incidence, and prognosis in neuroendocrine tumors: a population based study from a cancer registry.
    Caldarella A; Crocetti E; Paci E
    Pathol Oncol Res; 2011 Sep; 17(3):759-63. PubMed ID: 21476126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project.
    van der Zwan JM; Trama A; Otter R; Larrañaga N; Tavilla A; Marcos-Gragera R; Dei Tos AP; Baudin E; Poston G; Links T;
    Eur J Cancer; 2013 Jul; 49(11):2565-78. PubMed ID: 23541566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of gastrointestinal stromal tumors in Taiwan, 1998-2008: a nation-wide cancer registry-based study.
    Chiang NJ; Chen LT; Tsai CR; Chang JS
    BMC Cancer; 2014 Feb; 14():102. PubMed ID: 24548660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of the Incidence and Survival Patterns of Lung Cancer by Histologies, Including Rare Subtypes, in the Era of Molecular Medicine and Targeted Therapy: A Nation-Wide Cancer Registry-Based Study From Taiwan.
    Chang JS; Chen LT; Shan YS; Lin SF; Hsiao SY; Tsai CR; Yu SJ; Tsai HJ
    Medicine (Baltimore); 2015 Jun; 94(24):e969. PubMed ID: 26091466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.